SCHEMBL20047519

SCHEMBL20047519

CC(C)(C)c1cnc(C(C)(C)I)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18532660 0.89
SCHEMBL1754099 0.84 SLC6A3 (0.36)
SCHEMBL21775958 0.83 SLC6A3 (0.33)
SCHEMBL15491904 0.80 PDPK1 (0.30)
SCHEMBL16154673 0.78
SCHEMBL18179469 0.78 ALDH1A1 (0.31)
SCHEMBL22868188 0.77
SCHEMBL18760827 0.75
SCHEMBL24415626 0.74
SCHEMBL16809690 0.73 PDPK1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339971-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2023-10-26 US disclosed
EP-3306690-B1 ORGANIC SEMICONDUCTING COMPOUNDS RAYNERGY TEK INC (TW) 2022-09-07 EP disclosed
US-20200066998-A1 ORGANIC SEMICONDUCTING COMPONDS MERCK PATENT GMBH (DE) 2020-02-27 US disclosed
US-10450306-B2 Isoxazole analogs as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2019-10-22 US disclosed
US-20180099957-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-04-12 US disclosed